NCT00004907View on ClinicalTrials.gov

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Lymphoma
Interventions
DRUG

busulfan

DRUG

cyclophosphamide

DRUG

etoposide

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

60611

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00004907 - Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter